Print Page | Close Page
Dermaliq Therapeutics
Address:
1201 North Market Street,, Suite 111,, Wilmington, DE 19801
Country:
USA
Sectors:
Collaborations & Partnerships- R&D, Collaborations & Partnerships-Licensing, Collaborations & Partnerships-Services, Collaborations & Partnerships-Manufacture, Contract Research & Development, Contract Manufacturing, Proprietary Research & Manufacture
Website:
https://dermaliq.com/
- - -
Sectors
- Collaborations & Partnerships- R&D
- Collaborations & Partnerships-Licensing
- Collaborations & Partnerships-Services
- Collaborations & Partnerships-Manufacture
- Contract Research & Development
- Contract Manufacturing
- Proprietary Research & Manufacture
- - -
Categories
- Drug Delivery Technology
- Liposomes
- Lipids
- Lipid Based Emulsifiers
- Lipid Nanoparticles (LNPs)
- Lipid Emulsions
- Excipients
- Subcutaneous Delivery
- Clinical Development-Pipeline
- Dermatology products
- Topicals
- Prescription Based Medicines
- OTC Products
- Cosmeceuticals
- Bioavailability enhancement
- - -
News
03rd June 2025
DEBRA Research and Dermaliq Enter into a Strategic Collaboration to Advance Cutaneous Drug Delivery for Epidermolysis Bullosa
Munich, Germany and Wilmington, DE, U.S., 28 May 2025 – DEBRA Research gGmbH, a global nonprofit organization dedicated to advancing research and drug development for those affected by Epidermolysis Bullosa (EB), and Dermaliq Therapeutics, Inc., a clinical-stage dermatology innovator company developing next-generation topical therapies, today announced a strategic, non-exclusive collaboration to advance cutaneous drug delivery into the skin for EB. Initially, the partners will focus on improving wound-healing and anti-itch therapies, plus developing prophylactic therapies for people suffering from EB. As part of the agreement, DEBRA Research has also made a strategic investment in Dermaliq.
- - -
Printed: 15-Apr-2026 at 23:24:25 hrs
Source: The Partnership Tree | https://www.pharmaservicesdirectory.com